Search Results
Dr. Sara Tolaney on Eribulin Plus Pembrolizumab for Metastatic Triple-Negative Breast Cancer
Dr. Tolaney on Pembrolizumab Plus Eribulin in TNBC
Dr. Tolaney on Abemaciclib Plus Pembrolizumab for HR+, HER2- Breast Cancer
A Study Investigating Pembrolizumab in Combination With Eribulin in TNBC
SABCS 2016 - Sara Tolaney
Eribulin in Recurrent Metastatic ER+ Breast Cancer
Eribulin as Treatment for Metastatic Breast Cancer
Dr. Nanda On Pembrolizumab Potential for TNBC
Secondary Endpoints From a Trial of Pembrolizumab Plus Chemotherapy for Metastatic TNBC
Dr. Alvarez on Updated Findings With Eribulin in Patients With HER2+ Breast Cancer
Dr. Schmid on Benefit of Pembrolizumab in Patients With TNBC
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer